Quick Heal Technologies Limited (QUICKHEAL)
Outcome of Board Meeting
Q2FY27 results (unaudited):
Standalone:
Revenue 64.9bn -22% y-y (83.5bn)
EBITDA 2.3bn -75% y-y (9.2bn)
EBITDA margin 3.5% (11.1%) -760 bps y-y
PAT 5.8bn -27% y-y (7.9bn)
Consolidated:
Revenue 64.9bn -22% y-y (83.5bn)
EBITDA 2.3bn -75% y-y (9.2bn)
EBITDA margin 3.5% (11.1%) -760 bps y-y
PAT 5.8bn -27% y-y (7.9bn)
H1FY27 results (unaudited):
Standalone:
Revenue 109.9bn -22% y-y (140.8bn)
EBITDA 5.0bn +43% y-y (3.5bn)
PAT 0.7bn -80% y-y (3.5bn)
Consolidated:
Revenue 109.9bn -22% y-y (140.8bn)
EBITDA 5.0bn +43% y-y (3.5bn)
PAT 0.5bn -79% y-y (2.4bn)
FY26 results (audited):
Standalone:
Revenue 261.1bn
EBITDA not defensibly derivable
PAT -10.4bn
Consolidated:
Revenue 261.0bn
EBITDA not defensibly derivable
PAT -10.9bn
Dividend: None declared
Commentary: Company highlights improved Q2 operating performance with return to positive EBITDA and PAT, strategic customer wins in Defence, BFSI and IT sectors, and focus on enterprise growth and tighter credit controls in consumer business.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 QUICKHEAL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add QUICKHEAL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Quick Heal Technologies Limited
Important.
The summary above is generated automatically from Quick Heal Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.